Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management
Open Access
- 15 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 30 (3) , 217-228
Abstract
Purpose of review: This review addresses the escalating global challenge of multidrug-resistant tuberculosis (MDR-TB) in Sub-Saharan Africa, with a focus on its complex comorbidity with HIV/AIDS. Emphasizing the urgency of the issue, the review aims to shed light on the unique healthcare landscape shaped by the convergence of high prevalence rates and intersecting complexities with HIV/AIDS in the region. Recent findings: A notable increase in MDR-TB cases across Sub-Saharan Africa is attributed to challenges in timely diagnoses, treatment initiation, and patient treatment defaulting. The literature underscores the critical need for proactive measures to address diagnostic and treatment gaps associated with MDR-TB, particularly concerning its comorbidity with HIV/AIDS. Summary: To effectively manage MDR-TB and its co-morbidity with HIV/AIDS, proactive screening programs are imperative. The review highlights the necessity of active follow-up strategies to ensure treatment adherence and reduce default rates, offering evidence-based insights for improved disease management in the region.Keywords
This publication has 68 references indexed in Scilit:
- Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluationThe Lancet Microbe, 2023
- Surveillance of multidrug-resistant tuberculosis in sub-Saharan Africa through wastewater-based epidemiologyHeliyon, 2023
- Risk factors for multidrug-resistant tuberculosis in the Central African Republic: A case-control studyJournal of Infection and Public Health, 2023
- Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in Northwest EthiopiaJournal of Global Antimicrobial Resistance, 2022
- Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central AfricaInfection, 2022
- Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort studyThe Lancet Infectious Diseases, 2022
- Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort studyThe Lancet Global Health, 2022
- Genetic Diversity and Transmission of Multidrug-Resistant Mycobacterium tuberculosis strains in Lusaka, ZambiaInternational Journal of Infectious Diseases, 2022
- Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testThe Lancet Infectious Diseases, 2013
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisThe Lancet, 2010